All In MedTech

FDA Clearance Tracker · P030023-S009

Capsular Tension Ring (CTR) and RingJect

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Aug 1, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Aug 1, 2024

Approved

Time to decision

855 days

Received Mar 30, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P030023-S009
Device name
Capsular Tension Ring (CTR) and RingJect
Applicant
Ophtec BV
Applicant location
Groningen
Received
Mar 30, 2022
Decided
Aug 1, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P030023

Device type

Device class
Class III
Specialty
Ophthalmology

Every decision under product code MRJ

FDA's approval statement

As written in FDA's record.

approval for a manufacturing site located at Sterigenics Germany GmbH, FEI 3006003617, Kasteler Str. 45 Wiesbaden Hesse, 65203, Germany, for Ethylene Oxide Sterilization of Capsular Tension Ring (CTS) and RingJect.

Source documents

Other decisions for Ophtec BV

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.